Protective effect of a brisk tumor infiltrating lymphocyte infiltrate in melanoma: An EORTC melanoma group study
Alan Spatz(Jewish General Hospital), M. C. Mihm(St George's Hospital), D. J. Ruiter(Radboud University Nijmegen), Neil Desai(St George's Hospital), Ulrich Keilholz(German Cancer Research Center), Joost J. van den Oord(KU Leuven), Martin Cook(Royal Surrey NHS Foundation Trust), A.M.M. Eggermont(Praxis für Hämatologie und Onkologie), Phyllis A. Gimotty(University of Pennsylvania)
Cited by 4
Related Papers
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
|Science|2018|1.5k
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
|Cancer Cell|2013|680
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
|The Lancet|2008|644
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|621